Orthotopic expression of human 15-lipoxygenase (LO)-1 in the dorsolateral prostate of normal wild-type C57BL/6 mouse causes PIN-like lesions

Prostaglandins and Other Lipid Mediators

Volumn 81, Issue 1-2, 2006, Pages 1-13

  Sen, Malabika ^a   McHugh, Kevin ^a   Hutzley, Justin ^a   Philips, Brian J ^a   Dhir, Rajiv ^b   Parwani, Anil V ^b   Kelavkar, Uddhav P ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

13 S Hydroxyoctadecadienoic acid (13 S HODE); 15 Lipoxygenase 1 (15 LO 1); C57BL 6 mouse; Fibroblast growth factor (FGF); Linoleic acid (LA); Prostate cancer

Indexed keywords

13 HYDROXYOCTADECADIENOIC ACID; ADENOVIRUS VECTOR; ARACHIDONATE 15 LIPOXYGENASE; FATTY ACID; FIBROBLAST GROWTH FACTOR; GREEN FLUORESCENT PROTEIN; KI 67 ANTIGEN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; EPITHELIUM CELL; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEOPLASM; NONHUMAN; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; STAINING; STROMA CELL; VIRAL GENE DELIVERY SYSTEM; WILD TYPE;

ADENOVIRIDAE; ANIMALS; ARACHIDONATE 15-LIPOXYGENASE; BIOLOGICAL MARKERS; CELL LINE; HUMANS; ISOENZYMES; KI-67 ANTIGEN; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; PROSTATE; PROSTATIC NEOPLASMS; RECOMBINANT FUSION PROTEINS;

EID: 33748757721     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2006.05.024     Document Type: Article

References (43)

1. Ford-Hutchinson A.W. Arachidonate 15-lipoxygenase; characteristics and potential biological significance. Eicosanoids 4 (1991) 65-74
2. Badr K.F. 15-Lipoxygenase products as leukotriene antagonists: therapeutic potential in glomerulonephritis. Kidney Int Suppl 38 (1992) S101-S108
3. Kelavkar U., Glasgow W., and Eling T.E. The effect of 15-lipoxygenase-1 expression on cancer cells. Curr Urol Rep 3 (2002) 207-214
4. Funk C.D. The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice. Biochim Biophys Acta 1304 (1996) 65-84
5. Brash A.R., Boeglin W.E., and Chang M.S. Discovery of a second 15S-lipoxygenase in humans. Proc Natl Acad Sci USA 94 (1997) 6148-6152
6. Shappell S.B., Boeglin W.E., Olson S.J., Kasper S., and Brash A.R. 15-Lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma. Am J Pathol 155 (1999) 235-245
7. Kelavkar U.P., Nixon J.B., Cohen C., Dillehay D., Eling T.E., and Badr K.F. Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis. Carcinogenesis 22 (2001) 1765-1773
8. Bryant R.W., Simon T.C., and Bailey J.M. Role of glutathione peroxidase and hexose monophosphate shunt in the platelet lipoxygenase pathway. J Biol Chem 257 (1982) 14937-14943
9. Kelavkar U.P., Cohen C., Kamitani H., Eling T.E., and Badr K.F. Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: correlation with Gleason staging. Carcinogenesis 21 (2000) 1777-1787
10. Kelavkar U.P., and Cohen C. 15-Lipoxygenase-1 expression upregulates and activates insulin-like growth factor-1 receptor in prostate cancer cells. Neoplasia 6 (2004) 41-52
11. Reddy N., Everhart A., Eling T., and Glasgow W. Characterization of a 15-lipoxygenase in human breast carcinoma BT-20 cells: stimulation of 13-HODE formation by TGF alpha/EGF. Biochem Biophys Res Commun 231 (1997) 111-116
12. Bertomeu M.C., Gallo S., Lauri D., et al. Interleukin 1-induced cancer cell/endothelial cell adhesion in vitro and its relationship to metastasis in vivo: role of vessel wall 13-HODE synthesis and integrin expression. Clin Exp Metastasis 11 (1993) 243-250
13. Ikawa H., Kamitani H., Calvo B.F., Foley J.F., and Eling T.E. Expression of 15-lipoxygenase-1 in human colorectal cancer. Cancer Res 59 (1999) 360-366
14. Shappell S.B., Olson S.J., Hannah S.E., et al. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma. Cancer Res 63 (2003) 2256-2267
15. Ghosh J., and Myers C.E. Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc Natl Acad Sci USA 95 (1998) 13182-13187
16. Gupta S., Srivastava M., Ahmad N., Sakamoto K., Bostwick D.G., and Mukhtar H. Lipoxygenase-5 is overexpressed in prostate adenocarcinoma. Cancer 91 (2001) 737-743
17. Shureiqi I., Wojno K.J., Poore J.A., et al. Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers. Carcinogenesis 20 (1999) 1985-1995
18. Shureiqi I., Xu X., Chen D., et al. Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression. Cancer Res 61 (2001) 4879-4884
19. Harats D., Ben-Shushan D., Cohen H., et al. Inhibition of carcinogenesis in transgenic mouse models over-expressing 15-lipoxygenase in the vascular wall under the control of murine preproendothelin-1 promoter. Cancer Lett 229 (2005) 127-134
20. Kwabi-Addo B., Ozen M., and Ittmann M. The role of fibroblast growth factors and their receptors in prostate cancer. Endocr Relat Cancer 11 (2004) 709-724
21. Kwabi-Addo B., Wang J., Erdem H., et al. The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer. Cancer Res 64 (2004) 4728-4735
22. Heer R., Douglas D., Mathers M.E., Robson C.N., and Leung H.Y. Fibroblast growth factor 17 is over-expressed in human prostate cancer. J Pathol 204 (2004) 578-586
23. Presta M., Dell'Era P., Mitola S., Moroni E., Ronca R., and Rusnati M. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16 (2005) 159-178
24. Dorkin T.J., Robinson M.C., Marsh C., Neal D.E., and Leung H.Y. aFGF immunoreactivity in prostate cancer and its co-localization with bFGF and FGF8. J Pathol 189 (1999) 564-569
25. Giri D., Ropiquet F., and Ittmann M. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. Clin Cancer Res 5 (1999) 1063-1071
26. Ittman M., and Mansukhani A. Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate. J Urol 157 (1997) 351-356
27. Ropiquet F., Giri D., Kwabi-Addo B., Mansukhani A., and Ittmann M. Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer. Cancer Res 60 (2000) 4245-4250
28. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., and Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95 (1998) 2509-2514
29. Kwong J., Chan F.L., Jiang S., et al. Differential expression of PSP94 in rat prostate lobes as demonstrated by an antibody against recombinant GST-PSP94. J Cell Biochem 74 (1999) 406-417
30. Park J.H., Walls J.E., Galvez J.J., et al. Prostatic intraepithelial neoplasia in genetically engineered mice. Am J Pathol 161 (2002) 727-735
31. Shappell S.B., Thomas G.V., Roberts R.L., et al. Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 64 (2004) 2270-2305
32. Cunha G.R., Hayward S.W., Dahiya R., and Foster B.A. Smooth muscle-epithelial interactions in normal and neoplastic prostatic development. Acta Anat (Basel) 155 (1996) 63-72
33. Kabalin J.N., Peehl D.M., and Stamey T.A. Clonal growth of human prostatic epithelial cells is stimulated by fibroblasts. Prostate 14 (1989) 251-263
34. Culig Z., Hobisch A., Cronauer M.V., et al. Regulation of prostatic growth and function by peptide growth factors. Prostate 28 (1996) 392-405
35. Chung L.W., and Davies R. Prostate epithelial differentiation is dictated by its surrounding stroma. Mol Biol Rep 23 (1996) 13-19
36. Story M.T., Hopp K.A., Meier D.A., Begun F.P., and Lawson R.K. Influence of transforming growth factor beta 1 and other growth factors on basic fibroblast growth factor level and proliferation of cultured human prostate-derived fibroblasts. Prostate 22 (1993) 183-197
37. Sappino A.P., Schurch W., and Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 63 (1990) 144-161
38. Ronnov-Jessen L., and Petersen O.W. Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest 68 (1993) 696-707
39. Kelavkar U.P., Glasgow W., Olson S.J., Foster B.A., and Shappell S.B. Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice. Neoplasia 6 (2004) 821-830
40. Kamitani H., Geller M., and Eling T. Expression of 15-lipoxygenase by human colorectal carcinoma Caco-2 cells during apoptosis and cell differentiation. J Biol Chem 273 (1998) 21569-21577
41. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2 (2002) 442-454
42. Zhang B., Cao H., and Rao G.N. Fibroblast growth factor-2 is a downstream mediator of PI3K-AKT signaling in 14, 15-epoxyericosatrienoic acid-induced angiogenesis. J Biol Chem (2005)
43. Kelavkar UP, Parwani A, Shappell S, Martin W. Conditional expression of human 15-lipoxygenase-1 in adult mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model. Neoplasia, in press.